Kozak & Associates’s CME Group CME Stock Holding History

Kozak & Associates’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8	Closed	-$2.18K	–	400
2025 Q1	$2.16K	Hold	8	–	–	﹤0.01%	363
2024 Q4	$1.86K	Buy	+8	New	+$1.84K	﹤0.01%	367

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Kozak & Associates's CME Position: Q2 2025 in Review

Kozak & Associates sold out of CME Group (CME) in Q2 2025, closing a stake of 8 shares — an estimated $2.18K sold.

Kozak & Associates first reported a position in CME in Q4 2024 and held it in 2 quarters. The position peaked at $2.16K in Q1 2025. 1,660 funds tracked by Wall St. Rank hold CME as of Q2 2025.

Kozak & Associates reported no remaining CME Group position as of Q2 2025 after selling out during the quarter.
Kozak & Associates sold 8 CME Group shares in Q2 2025, an estimated $2.18K.
Kozak & Associates first reported a position in CME Group in Q4 2024 and held it in 2 quarters.
Kozak & Associates's CME Group position peaked at $2.16K in Q1 2025.
1,660 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on Kozak & Associates's 13F filing for Q2 2025, filed 10 Jul 2025.